141 related articles for article (PubMed ID: 11016066)
1. [Current clinical immunology: a genetic and molecular perspective].
Carrión F; Figueroa FE; Rodríguez C
Rev Med Chil; 2000 Jun; 128(6):650-8. PubMed ID: 11016066
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biology in clinical immunology].
Widmer U; Bingisser R; Fontana A
Internist (Berl); 1994 Feb; 35(2):139-46. PubMed ID: 8150579
[No Abstract] [Full Text] [Related]
3. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
Liston A; Enders A; Siggs OM
Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
[TBL] [Abstract][Full Text] [Related]
4. [Immunodeficiencies: an overview and various diagnostic difficulties].
Fontán Casariego G
Sangre (Barc); 1999 Apr; 44(2):101-6. PubMed ID: 10382319
[No Abstract] [Full Text] [Related]
5. Molecular defects in T- and B-cell primary immunodeficiency diseases.
Cunningham-Rundles C; Ponda PP
Nat Rev Immunol; 2005 Nov; 5(11):880-92. PubMed ID: 16261175
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of primary immunodeficiencies.
Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
[No Abstract] [Full Text] [Related]
7. [Hereditary abnormalities in the immune system: physiology and treatment].
Fischer A
Bull Mem Acad R Med Belg; 2002; 157(10-12):479-84. PubMed ID: 12854187
[TBL] [Abstract][Full Text] [Related]
8. [The molecular basis of primary immunodeficiency syndrome and the current therapeutic approach for the disease].
Morio T
Rinsho Byori; 1999 Jun; 47(6):519-24. PubMed ID: 10434568
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for primary immunodeficiencies.
Thrasher AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for inherited immunodeficiencies.
Howe S; Thrasher AJ
Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
[TBL] [Abstract][Full Text] [Related]
11. Update on gene therapy of inherited immune deficiencies.
Engel BC; Kohn DB; Podsakoff GM
Curr Opin Mol Ther; 2003 Oct; 5(5):503-7. PubMed ID: 14601519
[TBL] [Abstract][Full Text] [Related]
12. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: MHC associations and therapeutic implications.
Holmes S; Friese MA; Siebold C; Jones EY; Bell J; Fugger L
Expert Rev Mol Med; 2005 Feb; 7(3):1-17. PubMed ID: 15710050
[TBL] [Abstract][Full Text] [Related]
14. Progress in primary immunodeficiency.
Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
[TBL] [Abstract][Full Text] [Related]
15. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
Allepuz Llop N; Pellejá Pellejá J
An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
[TBL] [Abstract][Full Text] [Related]
16. [Adenosine deaminase deficiency and severe combined immunodeficiency].
Ueland PM
Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
[No Abstract] [Full Text] [Related]
17. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
18. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
Hershfield MS
Eur J Immunol; 2005 Jan; 35(1):25-30. PubMed ID: 15580654
[TBL] [Abstract][Full Text] [Related]
19. [Immunology in the medical practice. XXXI. Hereditary immune deficiencies: relationship between clinical symptoms and abnormalities of the immune system].
Vossen JM; Kuijpers TW
Ned Tijdschr Geneeskd; 2000 Jul; 144(31):1474-80. PubMed ID: 10941433
[TBL] [Abstract][Full Text] [Related]
20. Targeting costimulatory pathways for tumor immunotherapy.
Ward RC; Kaufman HL
Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
